146 related articles for article (PubMed ID: 16412635)
1. A novel series of urea-based peptidomimetic calpain inhibitors.
Sanders ML; Donkor IO
Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
[TBL] [Abstract][Full Text] [Related]
3. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors.
Abell AD; Jones MA; Coxon JM; Morton JD; Aitken SG; McNabb SB; Lee HY; Mehrtens JM; Alexander NA; Stuart BG; Neffe AT; Bickerstaffe R
Angew Chem Int Ed Engl; 2009; 48(8):1455-8. PubMed ID: 19145612
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
Zeng Y; Li Q; Hanzlik RP; Aubé J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
[TBL] [Abstract][Full Text] [Related]
8. Derivatives of 3-sec-butyl-1-oxo-2,3-dihydroisoquinoline as inhibitors of mu-calpain.
Chicharro R; Alonso M; Mazo MT; Arán VJ; Herradón B
ChemMedChem; 2006 Jul; 1(7):710-4. PubMed ID: 16902923
[No Abstract] [Full Text] [Related]
9. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
[TBL] [Abstract][Full Text] [Related]
10. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of calpain inhibitory 6-pyridone 2-carboxamide derivatives.
Lee KY; Lee KS; Jin C; Lee YS
Eur J Med Chem; 2009 Mar; 44(3):1331-4. PubMed ID: 18396356
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
Jiao W; McDonald DQ; Coxon JM; Parker EJ
Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines.
Guan N; Korukonda R; Hurh E; Schmittgen TD; Donkor IO; Dalton JT
Int J Oncol; 2006 Sep; 29(3):655-63. PubMed ID: 16865282
[TBL] [Abstract][Full Text] [Related]
15. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
Donkor IO; Korukonda R; Huang TL; LeCour L
Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
[TBL] [Abstract][Full Text] [Related]
16. Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.
Micale N; Kozikowski AP; Ettari R; Grasso S; Zappalà M; Jeong JJ; Kumar A; Hanspal M; Chishti AH
J Med Chem; 2006 Jun; 49(11):3064-7. PubMed ID: 16722625
[TBL] [Abstract][Full Text] [Related]
17. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
[TBL] [Abstract][Full Text] [Related]
18. Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site.
Shirasaki Y; Miyashita H; Yamaguchi M; Inoue J; Nakamura M
Bioorg Med Chem; 2005 Jul; 13(14):4473-84. PubMed ID: 15921914
[TBL] [Abstract][Full Text] [Related]
19. Exploration of peptidyl hydrazones as water-soluble calpain inhibitors.
Nakamura M; Inoue J
Bioorg Med Chem Lett; 2002 Jun; 12(12):1603-6. PubMed ID: 12039572
[TBL] [Abstract][Full Text] [Related]
20. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.
Setti EL; Davis D; Janc JW; Jeffery DA; Cheung H; Yu W
Bioorg Med Chem Lett; 2005 Mar; 15(5):1529-34. PubMed ID: 15713422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
